Open AccessSorafenib use in patients with radioiodine-refractory differentiated thyroid cancer - A five-year experience at the ISSSTE National Medical Center 20 de Noviembre in Mexico City
Author(s) -
Alejandro Juárez-Ramiro,
Héctor Gurrola-Machuca,
Michael Villavicencio-Quejeiro,
Gabriela Núñez-Guajardo,
Jorge A. Salazar-Andrade,
Aura Argentina Erazo-Valle Solís,
María Guadalupe Cervantes-Sánchez,
Isabel A. Loya-Aguilar
Publication year - 2020
Publication title -
gaceta mexicana de oncología/gaceta mexicana de oncología
Language(s) - English
Resource type - Journals
eISSN - 2565-005X
pISSN - 1665-9201
DOI - 10.24875/j.gamo.19000289
Subject(s) - sorafenib , center (category theory) , thyroid cancer , medicine , refractory (planetary science) , mexico city , cancer , nuclear medicine , humanities , hepatocellular carcinoma , art , chemistry , crystallography , physics , astrobiology